Efficacy of medical compression stockings class I on the reduction of symptoms in patients with uncomplicated varicose veins DOI Creative Commons
Markus Stücker,

D. Brass,

Luis Möckel

et al.

VASA, Journal Year: 2024, Volume and Issue: 54(1), P. 67 - 72

Published: Nov. 25, 2024

Aim of this study was to analyze the effect medical compression stockings (MCS) class I (according German classification "RAL-GZ 387"; 18-21 mmHg) on symptoms in patients with uncomplicated varicose veins (C2s-C4a).

Language: Английский

The year in vascular medicine: Highlights in Vasa – European Journal of Vascular Medicine 2024 DOI
Christos Rammos, Stefano Barco, Christian‐Alexander Behrendt

et al.

VASA, Journal Year: 2025, Volume and Issue: 54(1), P. 1 - 4

Published: Jan. 1, 2025

Language: Английский

Citations

0
Uterine leiomyosarcoma as a rare cause of fatal retroperitoneal haemorrhage due to compression and rupture of the renal vein DOI Creative Commons

Giorgia Lodetti,

Stefano Tambuzzi,

Salvatore Andreola

et al.

Journal of Forensic and Legal Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 102804 - 102804

Published: Jan. 1, 2025

Language: Английский

Citations

0
The role of Bromelain and Liposomal Vitamin C in the treatment of chronic venous disease DOI Creative Commons
Giacomo Buso, Paolo Santini,

Francesca Ghirardini

et al.

VASA, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 19, 2025

Summary: Chronic venous disease (CVD) is a prevalent condition leading to significant morbidity and affecting quality of life. Among conservative treatment strategies, venoactive drugs are often recommended by major guidelines for the management CVD. Bromelain vitamin C now emerging as promising options in several chronic diseases owing their anti-inflammatory, immunoregulatory, antioxidant properties, though evidence remains scarce this setting. This systematic review literature, endorsed Italian Society Angiology Vascular Medicine ( Societa Italiana di Angiologia e Patologia Vascolare, SIAPAV), aims evaluate efficacy safety these compounds A comprehensive search yielded nine studies, two on bromelain seven C. No studies have evaluated effects alone or combination, whereas both molecules were administered combination with other nutritional supplements. Overall, CVD-related symptoms edema seem improve dietary supplement containing compounds, no issues reported. may thus represent attractive patients symptomatic CVD and/or presence edema, provided optimal place. Dedicated clinical needed clarify management.

Language: Английский

Citations

0
Beyond the Bite: How Mosquito Salivary Proteins Modulate Midgut Biology and Malaria Parasite Transmission DOI Creative Commons
Thiago Luiz Alves e Silva,

Renuka E. Joseph,

Joel Vega-Rodríguez

et al.

Current Opinion in Insect Science, Journal Year: 2025, Volume and Issue: unknown, P. 101363 - 101363

Published: March 1, 2025

Language: Английский

Citations

0
Early outcomes of the Third-generation of ClosureFast radiofrequency ablation for great saphenous vein reflux DOI
Domenico Baccellieri, Vincenzo Ardita,

Nicola Galati

et al.

VASA, Journal Year: 2025, Volume and Issue: unknown

Published: March 31, 2025

Summary: Background: This study aimed to assess the safety of third-generation ClosureFast catheter for radiofrequency ablation (RFA) in treatment great saphenous vein (GSV) reflux patients presenting a dedicated center. Materials and methods: All consecutive with incompetent GSV who underwent RFA between December 2023 May 2024 were retrospectively analyzed. The primary endpoints technical success postoperative complication rate at 30 days. Secondary freedom from recanalization recurrent varicose (RVV) over follow-up. improvement symptoms (measured by Venous Clinical Severity Score [VCSS]) was evaluated. Results: During period, 50 limbs treated (mean age 55.8±13.4 years; 56% women; CEAP 2-4; VCSS >5). achieved 100% cases. There no significant incidence 30-day complications. instances deep venous thrombosis or puncture site thermal injury. One patient (2%) had hyperpigmentation; two (4%) ecchymosis; 4 (8%) pain. At mean follow-up 2.9±1.4 months, occlusion reintervention rates both within 1 week days respectively. No RVV score decreased median 3.5 (IQR: 2.4–5) points baseline (p<0.01). class 1.59 baseline, reflecting shift towards milder disease categories (C0–C2). Conclusions: third generation is safe effective ablate low perioperative period. However, durability further studies larger cohorts are still needed confirm these outcomes.

Language: Английский

Citations

0
Advances in the management of venous thromboembolism DOI
Gábor Forgó,

Stefano Barco

VASA, Journal Year: 2024, Volume and Issue: 54(1), P. 5 - 6

Published: Nov. 25, 2024

Language: Английский

Citations

1
Efficacy of medical compression stockings class I on the reduction of symptoms in patients with uncomplicated varicose veins DOI Creative Commons
Markus Stücker,

D. Brass,

Luis Möckel

et al.

VASA, Journal Year: 2024, Volume and Issue: 54(1), P. 67 - 72

Published: Nov. 25, 2024

Aim of this study was to analyze the effect medical compression stockings (MCS) class I (according German classification "RAL-GZ 387"; 18-21 mmHg) on symptoms in patients with uncomplicated varicose veins (C2s-C4a).

Language: Английский

Citations

0